REG - One Health Group PLC - Board Changes

One HealthAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260401:nRSA8671Ya&default-theme=true

RNS Number : 8671Y  One Health Group PLC  01 April 2026

 

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Board Changes

Appointment of Chief Financial Officer

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded
surgical procedures for patients referred by their GP through 'Patient
Choice', announces the appointment of Heather Craven as part-time Chief
Financial Officer ("CFO"). Heather will join the Board and assume the role of
CFO, both on a part‑time basis, with effect from 8 April 2026.

 

Heather Craven is an experienced Chartered Accountant with nearly nine years
as a Non-Executive Director and extensive experience as a Finance Director
across diverse FTSE, AIM and privately owned industries in the UK and
internationally. Her expertise spans corporate governance, financial controls,
risk management, funding, taxation, operational, financial and commercial
restructuring, strategic development and implementation, and managing external
relationships.

 

Most recently, Heather was Senior Independent Non-Executive Director at
Rotherham NHS Foundation Trust which included positions on numerous committees
across her tenure, including Chair of Finance and Operational Performance,
Vice Chair of Nomination and Remuneration and member of Audit and Risk and
Quality Assurance Committees. Heather's tenure as Independent Non-Executive
Director took place during a period of significant change and improvement
within the Trust, of which Heather was actively involved with shaping
strategy, strengthening governance and risk management as well as being
attached to a number of projects for additional scrutiny. This experience will
prove invaluable to One Health as the Company looks to open its first surgical
hub in 2027.

 

Prior to her role at Rotherham NHS Foundation Trust, Heather served as Interim
Finance Director and Controller in various companies, focusing on business
turnaround, refinancing, IPO preparation, integration consultancy, and
restructuring across sectors including logistics and food. Heather has also
held positions as Group Finance Director at Birse Group PLC and Finance
Director for European and American and African operations at Faber Prest PLC,
managing finance functions, corporate governance, restructuring, insurance,
taxation, commercial and financial negotiations, as well as all external
financial relationships.

 

One Health also announces that Shantanu Shahane will be retiring from the role
of Chief Medical Officer to concentrate on his clinical practice within One
Health Group. Professor Anil Hormis will be joining the Company as Associate
Medical Director from April to execute a timely handover process.

 

Adam Binns, Chief Executive Officer, commented: "I am delighted to welcome
Heather to the Board of One Health Group and very much look forward to the
wealth of knowledge she will bring to our business. Heather's experience
working with AIM listed companies and within an NHS Trust will be integral as
we enter a very exciting period of growth for the business with the build and
opening of our new surgical hub.

 

"Shantanu joined One Health as a Consultant Orthopaedic Surgeon in 2005 and
has grown with our business to Medical Director and most recently Chief
Medical Officer. I would like to thank Shantanu for his continued time and
commitment to One Health over the last 20 years and moving forward, as he
continues with his clinical practice as a Consultant within One Health Group."

 

Additional Information on the Board Appointment

The following additional information is provided with regards to the
appointment of Heather Ann Craven (nee Appleford and Rogerson), aged 64, in
accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

Heather does not currently hold any directorships or partnerships and has not
held any within the past five years.

Heather does not hold any shares or options in the Company.

 

There are no further disclosures required under Rule 17 and Schedule 2(g) of
the AIM Rules for Companies.

 

If you wish to keep up to date on Company news please email:
onehealth@walbrookpr.com (mailto:onehealth@walbrookpr.com)

 

For more information, please contact:

 

 One Health Group plc                                                                                                www.onehealth.co.uk/investors (http://www.onehealth.co.uk/investors)

 Derek Bickerstaff, Chairman                                                                                         Via Walbrook PR

 Adam Binns, CEO

 Panmure Liberum (Nominated Adviser and Broker)                                                                      Tel: +44 (0)20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

                                             (mailto:onehealth@walbrookpr.com)
 Alice Woodings / Paul McManus /

                                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
 Rachel Broad

                                               +44 (0)7747 515 393

 

About One Health Group plc (www.onehealth.co.uk (http://www.onehealth.co.uk) )

One Health engages 80 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and, in the year, to
March 2025 provided much needed care to 17,020 new patients, through over
42,000 consultations and over 7,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from over 60 NHS commissioning bodies in addition to contracts with
local NHS Hospital Trusts to transfer their internal waiting list patients to
One Health for quicker treatment.

 

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman
and Adam Binns, Chief Executive Officer, which offers insights into the
Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement
(https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOASDUSUFEMSEID



            Copyright 2019 Regulatory News Service, all rights reserved